(S)-tert-Butyl (pyrrolidin-2-ylmethyl)carbamatehydrochloride, 95.0%, 100mg

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 10g

8-Bromo-2,3-dihydro-1,4-benzodioxine-6-carboxylic acid, 98%, 2.5g

tert-Butyl 9-bromononanoate, 97%, 250mg

5-Bromo-1,10-phenanthroline>98.0%(T)1g

m,p-Ethylphenethyltrimethoxysilane, 95%, 25g

Methyl 3-(2,4-dichlorophenyl)-2-hydroxypropanoate, 97%, 50mg

Tetramethylhydroquinone; >95%, 95.0%, 5g

Dimethyl 5-(2-chloropropionamido)isophthalate, 95%, 2g

6-Bromo-1-naphthoic acid, 95.0%, 250mg

2-Chloro-N-[furan-2-yl(phenyl)methyl]acetamide, 95%, 1g

5-Bromo-3-methoxy-2-methylaniline, 95.0%, 100mg

(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg